IP Library Granted Patent US 7,442,813
Granted Patent B2
US 7,442,813 · App. 11/713,724 · Granted Oct 28, 2008

Process for producing dioxolane nucleoside analogues

Assignee: Shire Biochem Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,442,813
App. No.
11/713,724
Granted
Oct 28, 2008
Kind
B2
Abstract

The present invention relates to a process conducted in a single reaction vessel for producing a dioxolane nucleoside analogue of formula I or a pharmaceutically acceptable salt thereof; the process comprising the steps of adding a Lewis acid, a silylating agent and a non-silylated purine or pyrimidine base or an analogue thereof to a dioxolane of formula II. The invention also provides a process for producing a dioxolane compound of formula III; by reacting a dioxolane compound of formula IV in a suitable solvent in the presence of DIB and I 2 , using a suitable source of energy.

Claims (39)

1. A process for producing a dioxolane compound of formula III

said process comprising:

reacting a dioxolane compound of formula IV in a solvent;

in the presence of diacetoxy iodobenzene and I 2 , wherein said process is conducted using a source of energy; and wherein R 10 is a hydroxyl protecting group.

2. The process according to claim 1 , wherein the dioxolane compound of formula IV is added to a mixture of diacetoxy iodobenzene and I 2 .

3. The process according to claim 1 , further comprising reacting said dioxolane compound of formula IV in the presence acetic acid, wherein the dioxolane compound of formula IV is added to a mixture of diacetoxy iodobenzene, I 2 and acetic acid.

4. The process according to claim 1 , wherein R 10 is C 1-6 alkyl, C 6-12 aryl, C 6-12 arylalkyl, CO—C 1-6 alkyl, CO—C 1-6 alkoxy, CO—C 6-12 aryloxy, or CO—C 6-12 arylalkyl.

5. The process according to claim 4 , wherein R 10 is acetyl, pivaloyl, benzoyl, isopropyloxycarbonyl, or benzyl.

6. The process according to claim 4 , wherein R 10 is benzoyl.

7. The process according to claim 1 , wherein the solvent is toluene or dichloromethane.

8. The process according to claim 7 , wherein the solvent is dichloromethane.

9. The process according to claim 1 , wherein diacetoxy iodobenzene is used in a molar ratio of about 1.0 equivalent to about 2.5 equivalents with respect to the dioxolane compound of formula III.

10. The process according to claim 9 , wherein diacetoxy iodobenzene is used in a molar ratio of about 1.1 equivalent to about 1.5 equivalents with respect to the dioxolane compound of formula III.

11. The process according to claim 1 , wherein I 2 is used in a molar ratio of about 0.1 equivalent to about 1.0 equivalent with respect to the dioxolane compound of formula III.

12. The process according to claim 11 , wherein I 2 is used in a molar ratio of about 0.3 equivalent to about 0.5 equivalent with respect to the dioxolane compound of formula III.

13. The process according to claim 1 , wherein the source of energy is light.

14. The process according to claim 13 , wherein the source of energy is tungsten lamp light.

15. The process according to claim 13 , wherein the source of energy is daylight.

16. The process according to claim 1 , wherein the source of energy is heat.

17. A process for producing a dioxolane compound of formula III:

said process comprising:

reacting a dioxolane compound of formula IV in a solvent in the presence of diacetoxy iodobenzene and I 2 ;

wherein R 10 is acetyl, pivaloyl, benzoyl, benzyl, or isopropyloxycarbonyl, and

said dioxolane compound of formula IV is added to a mixture of diacetoxy iodobenzene and I 2 , and said process is conducted using a source of energy.

18. A process according to claim 17 , wherein diacetoxy iodobenzene is used in a molar ratio of about 1.0 equivalent to about 2.5 equivalents with respect to the dioxolane compound of formula III.

19. A process according to claim 17 , wherein diacetoxy iodobenzene is used in a molar ratio of about 1.1 equivalent to about 1.5 equivalents with respect to the dioxolane compound of formula III.

20. A process according to claim 17 , wherein I 2 is used in a molar ratio of about 0.1 equivalent to about 1.0 equivalent with respect to the dioxolane compound of formula III.

21. A process according to claim 17 , wherein I 2 is used in a molar ratio of about 0.3 equivalent to about 0.5 equivalent with respect to the dioxolane compound of formula III.

22. A process for producing a dioxolane compound of formula III:

said process comprising:

reacting a dioxolane compound of formula IV in a solvent in the presence of diacetoxy iodobenzene and I 2 ;

wherein

the dioxolane compound of formula IV is added to a mixture of diacetoxy iodobenzene, I 2 and acetic acid,

R 10 is acetyl, pivaloyl, benzoyl, benzyl, or isopropyloxycarbonyl; and

said process is conducted using a source of energy.

23. A process according to claim 22 , wherein diacetoxy iodobenzene is used in a molar ratio of about 1.0 equivalent to about 2.5 equivalents with respect to the dioxolane compound of formula III.

24. A process according to claim 22 , wherein diacetoxy iodobenzene is used in a molar ratio of about 1.1 equivalent to about 1.5 equivalents with respect to the dioxolane compound of formula III.

25. A process according to claim 22 , wherein I 2 is used in a molar ratio of about 0.1 equivalent to about 1.0 equivalent with respect to the dioxolane compound of formula III.

26. A process according to claim 22 , wherein I 2 is used in a molar ratio of about 0.3 equivalent to about 0.5 equivalent with respect to the dioxolane compound of formula III.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2021
From: TAKEDA CANADA INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055963/0992 →
Continuity (3)
Division 1050244000
Provisional Application 6035096800 · Jan 25, 2002
Related Publication 20070197784A1 · Aug 23, 2007